New 'Guide' program aims to make cancer trials more inclusive
NCT ID NCT06484595
First seen Jan 16, 2026 · Last updated Jun 19, 2026 · Updated 31 times
Summary
This completed pilot study tested a program called GUIDE, which assigns a trained navigator to help cancer patients overcome social and financial barriers to joining clinical trials. The study included 100 adults with cancer who were already eligible for a trial but had at least one health-related social need, like food or housing insecurity. Researchers wanted to see if patients and staff found the program helpful and practical.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Patient navigation program (GUIDE)
What this could lead to
If successful, this program could help more people from diverse backgrounds participate in cancer clinical trials, making future treatments more representative.
What could go wrong
This is a small pilot study focused on measuring how patients and staff perceive the program, not on whether it actually increases trial enrollment or improves health outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.